A Complete Response Case in a Patient with Multiple Lung Metastases of Rectal Cancer Treated with Bevacizumab plus XELIRI Therapy

It has been reported that many patients with lung metastasis of colorectal cancer (CRC) underwent chemotherapy with fluorouracil, folinic acid, oxaliplatin, irinotecan, or capecitabine. There is a small number of reports about the capecitabine and irinotecan (XELIRI) plus bevacizumab (BV) therapy fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashida, Hiroki, Satake, Hironaga, Kaihara, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301106/
https://www.ncbi.nlm.nih.gov/pubmed/28203168
http://dx.doi.org/10.1159/000455899
_version_ 1782506301360701440
author Hashida, Hiroki
Satake, Hironaga
Kaihara, Satoshi
author_facet Hashida, Hiroki
Satake, Hironaga
Kaihara, Satoshi
author_sort Hashida, Hiroki
collection PubMed
description It has been reported that many patients with lung metastasis of colorectal cancer (CRC) underwent chemotherapy with fluorouracil, folinic acid, oxaliplatin, irinotecan, or capecitabine. There is a small number of reports about the capecitabine and irinotecan (XELIRI) plus bevacizumab (BV) therapy for patients with metastatic CRC in Japan. We report a case of successful BV+XELIRI therapy for rectal cancer with multiple lung metastases as first-line chemotherapy. A 53-year-old female presented with advanced rectal cancer and metastatic lung tumors. Following surgery, the patient was treated with XELIRI+BV. After 6 courses, a computed tomography scan showed complete response of the lung metastases. No recurrence has occurred for 3 years after chemotherapy was stopped.
format Online
Article
Text
id pubmed-5301106
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-53011062017-02-15 A Complete Response Case in a Patient with Multiple Lung Metastases of Rectal Cancer Treated with Bevacizumab plus XELIRI Therapy Hashida, Hiroki Satake, Hironaga Kaihara, Satoshi Case Rep Oncol Case Report It has been reported that many patients with lung metastasis of colorectal cancer (CRC) underwent chemotherapy with fluorouracil, folinic acid, oxaliplatin, irinotecan, or capecitabine. There is a small number of reports about the capecitabine and irinotecan (XELIRI) plus bevacizumab (BV) therapy for patients with metastatic CRC in Japan. We report a case of successful BV+XELIRI therapy for rectal cancer with multiple lung metastases as first-line chemotherapy. A 53-year-old female presented with advanced rectal cancer and metastatic lung tumors. Following surgery, the patient was treated with XELIRI+BV. After 6 courses, a computed tomography scan showed complete response of the lung metastases. No recurrence has occurred for 3 years after chemotherapy was stopped. S. Karger AG 2017-01-17 /pmc/articles/PMC5301106/ /pubmed/28203168 http://dx.doi.org/10.1159/000455899 Text en Copyright © 2017 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Hashida, Hiroki
Satake, Hironaga
Kaihara, Satoshi
A Complete Response Case in a Patient with Multiple Lung Metastases of Rectal Cancer Treated with Bevacizumab plus XELIRI Therapy
title A Complete Response Case in a Patient with Multiple Lung Metastases of Rectal Cancer Treated with Bevacizumab plus XELIRI Therapy
title_full A Complete Response Case in a Patient with Multiple Lung Metastases of Rectal Cancer Treated with Bevacizumab plus XELIRI Therapy
title_fullStr A Complete Response Case in a Patient with Multiple Lung Metastases of Rectal Cancer Treated with Bevacizumab plus XELIRI Therapy
title_full_unstemmed A Complete Response Case in a Patient with Multiple Lung Metastases of Rectal Cancer Treated with Bevacizumab plus XELIRI Therapy
title_short A Complete Response Case in a Patient with Multiple Lung Metastases of Rectal Cancer Treated with Bevacizumab plus XELIRI Therapy
title_sort complete response case in a patient with multiple lung metastases of rectal cancer treated with bevacizumab plus xeliri therapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301106/
https://www.ncbi.nlm.nih.gov/pubmed/28203168
http://dx.doi.org/10.1159/000455899
work_keys_str_mv AT hashidahiroki acompleteresponsecaseinapatientwithmultiplelungmetastasesofrectalcancertreatedwithbevacizumabplusxeliritherapy
AT satakehironaga acompleteresponsecaseinapatientwithmultiplelungmetastasesofrectalcancertreatedwithbevacizumabplusxeliritherapy
AT kaiharasatoshi acompleteresponsecaseinapatientwithmultiplelungmetastasesofrectalcancertreatedwithbevacizumabplusxeliritherapy
AT hashidahiroki completeresponsecaseinapatientwithmultiplelungmetastasesofrectalcancertreatedwithbevacizumabplusxeliritherapy
AT satakehironaga completeresponsecaseinapatientwithmultiplelungmetastasesofrectalcancertreatedwithbevacizumabplusxeliritherapy
AT kaiharasatoshi completeresponsecaseinapatientwithmultiplelungmetastasesofrectalcancertreatedwithbevacizumabplusxeliritherapy

Ejemplares similares